Found 11 matching trials
Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection PHASE2 Primary objectives:
The purpose of this study is to determine and compare ...
Show More Location
Changhua Christian Hospital
Learn More & Join Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients PHASE2 To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Show More Learn More & Join Trial
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) PHASE3 The purpose of this study is to estimate efficacy, as determined by the pro...
Show More Location
The Health Care Authority For Baptist Health
Learn More & Join Trial
Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) PHASE3 The purpose of this study is to assess efficacy, as determined by the propo...
Show More Location
Alabama Liver & Digestive Specialists (Alds)
Learn More & Join Trial
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) PHASE3 The purpose of this study is to treat human immunodeficiency virus (HIV) an...
Show More Learn More & Join Trial
A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection PHASE2 The purpose of this study is to investigate how efficient TMC435350 will wo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment PHASE2 The purpose of this study is to determine the efficacy, safety and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment PHASE2 The purpose of this study is to evaluate the efficacy of 4 different regime...
Show More Location
Multiple Locations
Learn More & Join Trial
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection PHASE3 The purpose of this study is to evaluate the effectiveness of telaprevir ad...
Show More Location
Multiple Locations
Learn More & Join Trial
Boceprevir in End Stage Renal Disease (ESRD) NA The purpose of the study is to assess the safety and efficacy of triple the...
Show More Location
Multiple Locations
Learn More & Join Trial